SEC Company Response from Nomadar (NOMA) — Feb 5, 2025
Nomadar Corp.
Date: Feb. 5, 2025 · CIK: 0001994214 · Accession: 0001493152-25-005057
AI Filing Summary & Sentiment
Referenced dates: January 14, 2025
Show Raw Text
CORRESP
1
filename1.htm
Jeffrey
Baumel
Jeffrey.baumel@dentons.com
D
+1 973 912 7189
Dentons
US LLP
1221
Avenue of the Americas
New
York, NY 10020-1089
United
States
dentons.com
February
5, 2025
Privileged
and Confidential
VIA
EDGAR
Kate
Beukenkamp
Donald
Field
Ta
Tanisha Meadows
Adam
Phippen
Securities
and Exchange Commission
Division
of Corporation Finance
Office
of Trade & Services
100
F Street, N.E.
Washington,
DC 20549
Re:
Nomadar
Corp.
Amendment
No. 2 to Draft Registration Statement on Form S-1
Filed
December 19, 2024
CIK
No. 0001994214
Dear
Mr. Beukenkamp and Mr. Field:
By
your letter dated January 14, 2025 (the “SEC Letter”), the staff of the Division of Corporation Finance of
the Securities and Exchange Commission (the “Staff”) provided comments to the Amendment No. 2 to the Draft
Registration Statement on Form S-1 (the “Amendment No. 2”), submitted to the Staff on December 19, 2024,
by our client, Nomadar Corp. (the “Company”). This letter sets forth our response with respect to the comments
contained in the SEC Letter.
Concurrently
herewith, we are filing the Registration Statement (“Registration Statement”) via the EDGAR system. The changes
made to the Registration Statement reflect the responses of the Company to the Staff’s comments as set forth in the SEC Letter
regarding Amendment No. 2.
The
Company has asked us to convey the following as its responses to the Staff.
Amendment
No. 2 to Registration Statement on Form S-1 Submitted December 20, 2024
Organization
Structure, page 7
1.
We
note your response to prior comment 6 and reissue in part. Please revise your organizational structure to reflect the Class A and
Class B holdings and respective voting power held by public, non-affiliated, stockholders. We note that “Other Registered Stockholders”
reflected in the diagram includes Nomadar directors and officers.
Response:
The Company respectfully advises the Staff that it has revised the organizational structure table in the Registration Statement
to reflect the Class A and Class B holdings and respective voting power held by public, non-affiliated, stockholders. Please
see pages 7 and 57 of the Registration Statement for more information.
February
5, 2025
Page
2
dentons.com
Prospectus
Summary
Capital
Requirements, page 7
2.
We
note your response to prior comment 2 and reissue in part. Please revise your disclosure here and in your risk factor beginning “We
will need additional capital to fund...”, similar to your cover page, to state clearly that you currently do not have the required
funding to develop Sportech City. We note your statement that a mixed financing plan has been “at least formulated.”
Response:
The Company respectfully advises the Staff that it has revised the disclosure in the Registration Statement to state clearly
that the Company currently does not have the required funding to develop Sportech City. Please see pages 7 and 9 of
the Registration Statement for more information.
Risk
Factors
Risks
Related to This Direct Listing and Ownership of Our Common Stock
We
will be a “controlled company” within the meaning of the Nasdaq Stock Market..., page 29
3.
We
note your response to prior comment 1 and reissue in part. Please further revise your disclosure here to state specifically the matters
that the controlling shareholders have the ability to control requiring shareholder approval (i.e., the election of directors, amendment
of the organizational documents, and approval of major corporate transactions, such as a change in control, consolidation, or sale
of the company or assets).
Response:
The Company respectfully advises the Staff that it has revised the disclosure in the Registration Statement to state
specifically examples the matters that the controlling shareholders have the ability to control requiring shareholder approval. Please
see page 29 of the Registration Statement for more information.
If
you have any questions, or if we may be of any assistance, please do not hesitate to contact the undersigned at 973-912-7189 or Jeffrey.baumel@dentons.com
or Grant Levine at 212-768-5384 or grant.levine@dentons.com, respectively.
Very
truly yours,
/s/
Jeffrey Baumel
Jeffrey
Baumel
JB